Drug intelligence / Profile preview

Dotoux Plus

Development stage
Unknown
Lead developer
Domesco Medical Import-Export
Modality
Small Molecules
Administration
Oral
01

Overview

Dotoux Plus is a multi-ingredient oral medication developed and manufactured by Domesco Medical Import Export Joint Stock Corporation, a leading pharmaceutical company in Vietnam. It is formulated as a combination of three active small molecule ingredients: paracetamol (acetaminophen), phenylephrine hydrochloride, and chlorpheniramine maleate. Paracetamol serves as an analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. Phenylephrine acts as a sympathomimetic decongestant by stimulating alpha-1 adrenergic receptors, leading to vasoconstriction in the nasal mucosa and reducing congestion. Chlorpheniramine is a first-generation antihistamine that competitively blocks H1 receptors, alleviating symptoms such as sneezing, itching, and rhinorrhea. This combination is primarily indicated for the symptomatic relief of pain, fever, and nasal congestion associated with the common cold, influenza, and allergic rhinitis.

Brand names
Dotoux Plus
Other names
paracetamol + phenylephrine + chlorpheniramine
02

Targets

HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRA1A (α1A)

Beyond the preview

Go deeper on Dotoux Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dotoux Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call